We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Real‐world treatment patterns and clinical outcomes among follicular lymphoma patients in the SEER‐Medicare population.
- Authors
Chihara, D.; Yang, S.; Chawla, S. Bains; Zhang, G.; Wang, A.; Yu, J.; Arnette, D.; Navarro, F. Rivas; Blaedel, J.; Mutebi, A.
- Abstract
A new line of therapy (LOT) was defined when next lymphoma directed treatment was started (including retreatment of anti-CD20 mab) after 180 days from completion of previous treatment. Patients experiencing POD24 showed shorter OS than other patients (median OS: 67.5 vs. 103.8 months; hazard ratio [HR] 1.61; 95% CI: 1.46, 1.79). The median EFS becomes shorter with later lines of treatment, indicating unmet needs for effective and tolerable therapies in patients with FL.
- Subjects
FOLLICULAR lymphoma; TREATMENT effectiveness; OLDER patients; CANCER treatment
- Publication
Hematological Oncology, 2023, Vol 41, p372
- ISSN
0278-0232
- Publication type
Article
- DOI
10.1002/hon.3164_269